CDC / RDC · All levels
CDC Review Gate: Step-by-Step Walkthrough
Step-by-Step Walkthrough for CDC Review Gate.
Step-by-step analysis walkthrough
Use this sequence when owning CDC Review Gate in a signoff review.
Inspect warning class and severity.
Trace crossing endpoints and domains.
Check protocol/reset assumptions against spec.
Review synchronizer or FIFO implementation detail.
Run focused assertion or formal check.
Draft fix options with risk and schedule impact.
Execute regression and publish closure memo.
Artifacts to collect
review checklist, gate scorecard, escalation log
crossing inventory
waiver board notes
regression report
Decision memo template
CDC/RDC DECISION MEMO — CDC Review Gate
risk class:
mechanism:
evidence:
fix/waiver:
owners: program lead, CDC owner, integration leadReference visuals
Review gate criteria
Gate inputs:
- zero critical unowned CDC issues
- formal/sim evidence for protocol crossings
- waiver aging below thresholdCDC/RDC deep dive
Signoff is an evidence governance problem across teams.
Concept diagram
CDC SIGNOFF LOOP
analysis -> triage -> fix/waive -> review gate -> dashboardMetric graph
CRITICAL OPEN COUNT
week1 34
week2 22
week3 10
week4 0Reports and artifacts
critical by owner
waiver quality
review gate status
closure trend
Mini case study
Pass rates improved while critical waivers aged out of policy; dashboard exposed hidden risk.
Debug branches
Separate quality from quantity metrics
enforce waiver expiry
run gate checklists consistently
Senior review question
Ask: what evidence proves this risk is closed for silicon, not just tool-clean?
Key takeaways
State crossing class, assumptions, and owner with every issue.
Run structural and dynamic regressions after each fix.
Common pitfalls
Treating all warnings as equivalent risk.
Waiving issues without containment evidence.
Skipping reset and reconvergence stress after CDC fixes.
Principal CDC/RDC review addendum
Gate reviews align RTL, verification, and signoff evidence before integration milestones to avoid endgame metastability surprises.
Metric: gate pass rate, late-stage CDC churn, review defect leakage